28 November 2024

Herbert Smith Freehills advises Vitrafy Life Sciences on its successful A$117.5 million IPO

Advising firms

4 lawyers named

The named deal team is included with full access

Full access shows the lawyers on every deal team, disclosed values, clients and counterparties.

Deal value, client and counterparties are included with full access

Full access shows the disclosed value and what it refers to, the client and every counterparty.